These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6463419)

  • 41. [Effects of disopyramide phosphate in repetitive paroxysmal ventricular tachycardia].
    Katoh T; Sasaki Y; Tsuda T
    Kokyu To Junkan; 1982 Sep; 30(9):959-64. PubMed ID: 7178700
    [No Abstract]   [Full Text] [Related]  

  • 42. Conversion of paroxysmal supraventricular tachycardia due to a concealed extranodal pathway with intravenous bolus of lidocaine.
    Rosen KM; Denes P; Wu D; Cummings J
    Chest; 1977 Jan; 71(1):78-80. PubMed ID: 830504
    [No Abstract]   [Full Text] [Related]  

  • 43. Intravenous verapamil in supraventricular tachyarrhythmias.
    Das JP; Bajoria SS
    J Assoc Physicians India; 1977 Jun; 25(6):385-9. PubMed ID: 612647
    [No Abstract]   [Full Text] [Related]  

  • 44. [On the clinical trial of disopyramide (Rhythmodan) in the prevention of attacks of supraventricular paroxysmal tachycardia].
    Masini G
    Minerva Med; 1970 Sep; 61(71 Suppl):3748-52. PubMed ID: 5454440
    [No Abstract]   [Full Text] [Related]  

  • 45. Correlation of disopyramide pharmacokinetics with efficacy in ventricular tachyarrhythmia.
    Rangno RE; Warnica W; Ogilvie RI; Kreeft J; Bridger E
    J Int Med Res; 1976; 4(1 Suppl):54-8. PubMed ID: 1026530
    [No Abstract]   [Full Text] [Related]  

  • 46. [Electrophysiologic characteristics and hemodynamic behavior of paroxysmal supraventricular tachycardia].
    Sganzerla P; Moruzzi P; Guazzi M
    Cardiologia; 1988 Sep; 33(9):867-73. PubMed ID: 3228813
    [No Abstract]   [Full Text] [Related]  

  • 47. [Programmed stimulation in studying and treating ventricular tachycardia].
    Jiang WP
    Zhonghua Xin Xue Guan Bing Za Zhi; 1986 Apr; 14(2):91-4. PubMed ID: 3488893
    [No Abstract]   [Full Text] [Related]  

  • 48. Long-term therapy with disopyramide phosphate: side effects and effectiveness.
    Bauman JL; Gallastegui J; Strasberg B; Swiryn S; Hoff J; Welch WJ; Bauernfeind RA
    Am Heart J; 1986 Apr; 111(4):654-60. PubMed ID: 3082173
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Disopyramide in pregnancy: a case report.
    Shaxted EJ; Milton PJ
    Curr Med Res Opin; 1979; 6(1):70-2. PubMed ID: 456013
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Electrophysiologic effect of intravenous amiodarone on patients with paroxysmal supraventricular tachycardia].
    Li ZC; Shi YS; Huang TG
    Zhonghua Nei Ke Za Zhi; 1985 Jun; 24(6):339-43, 381. PubMed ID: 4017749
    [No Abstract]   [Full Text] [Related]  

  • 51. Arrhythmias in infants and children.
    Shakibi JG
    Paediatrician; 1981; 10(1-3):117-22. PubMed ID: 7243302
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inducible sustained ventricular tachycardia refractory to individual class I drugs: effect of adding a second class I drug.
    Duffy CE; Swiryn S; Bauernfeind RA; Strasberg B; Palileo E; Rosen KM
    Am Heart J; 1983 Sep; 106(3):450-8. PubMed ID: 6881016
    [No Abstract]   [Full Text] [Related]  

  • 53. [Electrophysiological effects and mechanisms of antiarrhythmic action of nibentan in patients with paroxysmal arrhythmias].
    Golitsin SP
    Kardiologiia; 2003; 43(4):64-73. PubMed ID: 12968607
    [No Abstract]   [Full Text] [Related]  

  • 54. Two or more intra AV nodal pathways in association with either a James or Kent extranodal bypass in 3 patients with paroxysmal supraventricular tachycardia.
    Spurrell RA; Krikler D; Sowton E
    Br Heart J; 1973 Feb; 35(2):113-22. PubMed ID: 4690532
    [No Abstract]   [Full Text] [Related]  

  • 55. [The effect of a new calcium antagonist (Ro 11-1781) in supraventricular paroxysmal tachycardia].
    Gmeiner R; Ng CK; Gstöttner M; Schwenninger C
    Adv Clin Pharmacol; 1978; 16():81-102. PubMed ID: 356555
    [No Abstract]   [Full Text] [Related]  

  • 56. Effects of tocainide studied with programmed electrical stimulation of the heart in patients with reentrant tachyarrhythmias.
    Waleffe A; Bruninx P; Mary-Rabine L; Kulbertus HE
    Am J Cardiol; 1979 Feb; 43(2):292-9. PubMed ID: 760483
    [No Abstract]   [Full Text] [Related]  

  • 57. [Echocardiographic indices of cardiac function and systemic hemodynamics in patients with cardiac fibrillation paroxysms and their dynamics as affected by disopyramide phosphate].
    Komarov FI; Ol'binskaia LI; Kuz'mina MM
    Kardiologiia; 1985 Jul; 25(7):71-4. PubMed ID: 3932741
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Action of injectable disopyramide phosphate in the emergency treatment of ventricular tachycardia].
    Valère PE; Guerot C; Castillo Fenoy A; Branvin E; Urbanczyk A; Tricot R
    Coeur Med Interne; 1977; 16(2):285-92. PubMed ID: 891126
    [No Abstract]   [Full Text] [Related]  

  • 59. Serendipitous relief with disopyramide of phobia for flying.
    Lewis DO
    Am J Psychiatry; 1983 Oct; 140(10):1387. PubMed ID: 6624986
    [No Abstract]   [Full Text] [Related]  

  • 60. [Changes in atrioventricular and intraventricular conduction during paroxysmal tachycardia in infants].
    Baldini G; Macchia PA
    Arch Ital Pediatr Pueric; 1968; 26(3):200-4. PubMed ID: 5740684
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.